Nixon Peabody Trust CO Danaher Corp Transaction History

Nixon Peabody Trust CO

$1.18 Billion
Q3 2024

A detailed history of Nixon Peabody Trust CO transactions in Danaher Corp stock. As of the latest transaction made, Nixon Peabody Trust CO holds 61,194 shares of DHR stock, worth $14.1 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

61,194

Previous 60,559 1.05%

Holding current value

$14.1 Million

Previous $15.1 Million 12.43%

% of portfolio

1.44%

Previous 1.37%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$239.25 - $280.76 $151,923 - $178,282	635 Added 1.05%	61,194 $17 Million
Q2 2024 Jul 26, 2024	SELL	$235.51 - $267.98 $138,950 - $158,108	-590 Reduced 0.96%	60,559 $15.1 Million
Q1 2024 May 07, 2024	BUY	$224.58 - $256.19 $884,396 - $1.01 Million	3,938 Added 6.88%	61,149 $15.3 Million
Q4 2023 Feb 09, 2024	BUY	$185.1 - $233.13 $8.94 Million - $11.3 Million	48,278 Added 540.45%	57,211 $13.2 Million
Q3 2023 Oct 23, 2023	BUY	$233.08 - $265.59 $24,706 - $28,152	106 Added 1.2%	8,933 $2.22 Million
Q2 2023 Jul 27, 2023	SELL	$224.99 - $256.14 $464,604 - $528,929	-2,065 Reduced 18.96%	8,827 $2.12 Million
Q1 2023 May 12, 2023	BUY	$239.75 - $277.0 $167,105 - $193,069	697 Added 6.84%	10,892 $2.75 Million
Q4 2022 Feb 08, 2023	BUY	$241.42 - $282.29 $990,063 - $1.16 Million	4,101 Added 67.3%	10,195 $2.71 Million
Q3 2022 Mar 15, 2023	BUY	$247.06 - $1507.4 $11,117 - $67,833	45 Added 0.44%	10,240 $2.64 Million
Q3 2022 Nov 09, 2022	SELL	$247.06 - $1507.4 $3.62 Million - $22.1 Million	-14,656 Reduced 70.63%	6,094 $1.57 Million
Q2 2022 Aug 11, 2022	SELL	$237.11 - $299.66 $523,538 - $661,649	-2,208 Reduced 9.62%	20,750 $5.26 Million
Q1 2022 May 13, 2022	SELL	$257.27 - $315.76 $355,804 - $436,696	-1,383 Reduced 5.68%	22,958 $6.73 Million
Q4 2021 Feb 08, 2022	BUY	$292.08 - $329.01 $70,683 - $79,620	242 Added 1.0%	24,341 $8.01 Million
Q3 2021 Nov 04, 2021	SELL	$272.21 - $332.43 $20,687 - $25,264	-76 Reduced 0.31%	24,099 $7.34 Million
Q2 2021 Jul 30, 2021	SELL	$225.08 - $271.69 $405,594 - $489,585	-1,802 Reduced 6.94%	24,175 $6.49 Million
Q1 2021 Apr 26, 2021	SELL	$212.38 - $245.9 $28,458 - $32,950	-134 Reduced 0.51%	25,977 $5.85 Million
Q4 2020 Feb 10, 2021	SELL	$212.5 - $245.46 $383,562 - $443,055	-1,805 Reduced 6.47%	26,111 $5.8 Million
Q3 2020 Nov 03, 2020	SELL	$177.16 - $215.33 $401,798 - $488,368	-2,268 Reduced 7.51%	27,916 $6.01 Million
Q2 2020 Aug 13, 2020	BUY	$128.7 - $176.83 $123,165 - $169,226	957 Added 3.27%	30,184 $5.34 Million
Q1 2020 Apr 23, 2020	BUY	$121.39 - $169.05 $31,197 - $43,445	257 Added 0.89%	29,227 $4.05 Million
Q4 2019 Jan 24, 2020	BUY	$133.47 - $153.48 $16,683 - $19,185	125 Added 0.43%	28,970 $4.45 Million
Q3 2019 Nov 05, 2019	SELL	$135.4 - $146.47 $5,009 - $5,419	-37 Reduced 0.13%	28,845 $4.17 Million
Q2 2019 Aug 01, 2019	BUY	$124.88 - $143.73 $571,201 - $657,421	4,574 Added 18.82%	28,882 $4.13 Million
Q1 2019 Apr 19, 2019	BUY	$97.62 - $132.29 $221,695 - $300,430	2,271 Added 10.31%	24,308 $3.21 Million
Q4 2018 Jan 23, 2019	SELL	$94.85 - $109.54 $34,430 - $39,763	-363 Reduced 1.62%	22,037 $2.27 Million
Q3 2018 Oct 25, 2018	BUY	$98.13 - $108.9 $129,629 - $143,856	1,321 Added 6.27%	22,400 $2.43 Million
Q2 2018 Jul 30, 2018	BUY	$96.1 - $103.24 $4,805 - $5,162	50 Added 0.24%	21,079 $2.08 Million
Q1 2018 Apr 27, 2018	BUY	$92.16 - $103.8 $71,884 - $80,964	780 Added 3.85%	21,029 $2.06 Million
Q4 2017 Feb 05, 2018	BUY	$85.26 - $94.62 $47,916 - $53,176	562 Added 2.85%	20,249 $1.88 Million
Q3 2017 Nov 01, 2017	BUY	$79.29 - $88.45 $1.56 Million - $1.74 Million	19,687	19,687 $1.69 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nixon Peabody Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Nixon Peabody Trust CO with notifications on news.

Account

Nixon Peabody Trust CO Danaher Corp Transaction History